Rajni Srivastava

Rajni Srivastava has a diverse work experience spanning several companies and roles. Beginning in 2006, Rajni worked as a Research Scientist at Dabur Research Foundation for two years. They then joined Panacea Biotec Ltd, where they held various positions such as Executive, Sr. Executive, Assistant Manager, and Deputy Manager from 2008 to 2014. In 2015, Rajni worked at Sanofi as an Assistant Manager for one year before moving to Fresenius Kabi Oncology Limited - India. At Fresenius Kabi Oncology Limited, they served as an Assistant Manager from 2016 to 2017 and later became a Manager from 2017 to 2019. From 2019 to 2021, Rajni held managerial roles at BresMed, including Manager - Systematic Reviews and Director - Systematic Reviews. Currently, Rajni is working at Cytel as the Director - Systematic Literature Reviews, starting from November 2021.

Rajni Srivastava attended the Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR) from 2000 to 2004, where they obtained a Bachelor of Pharmacy degree. Rajni then continued their education at the same institution from 2004 to 2006, completing a Master of Pharmacy degree. No specific field of study was provided for either degree.